In CAR T cell-treated lymphomas, the T cell rich get richer

NATURE MEDICINE(2022)

引用 1|浏览6
暂无评分
摘要
In patients with large B cell lymphomas, immune features of the tumor microenviroment predict clinical outcomes after CAR T cell therapy; as the number of patients treated with CAR T cells is set to increase, refinement of these and other biomarkers will be crucial.
更多
查看译文
关键词
Biomarkers,Translational research,Biomedicine,general,Cancer Research,Metabolic Diseases,Infectious Diseases,Molecular Medicine,Neurosciences
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要